SHEREE LACOSTE: Open Payments
NPI 1730426925 · FOLEY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,746 in 135 payments from 23 companies in 2025. Trend: 2023 $2,241 · 2024 $4,076 · 2025 $3,746
Food & beverage: $3,642Education: $103
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $846 |
| Janssen Biotech, Inc. | 22 | $386 |
| Galderma Laboratories, L.P. | 8 | $363 |
| GENZYME CORPORATION | 8 | $280 |
| Incyte Corporation | 6 | $256 |
| LEO Pharma Inc. | 6 | $206 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 10 | $183 |
| Janssen Scientific Affairs, LLC | 2 | $169 |
| Novartis Pharmaceuticals Corporation | 6 | $142 |
| Mallinckrodt Hospital Products Inc. | 4 | $124 |
Products named: TREMFYA, DUPIXENT, NEMLUVIO, RINVOQ, SKYRIZI, OPZELURA, ACTHAR, ADBRY.
Industry payments across AL — which companies pay providers there.
